Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation.

Papastefanou VP, Nogueira V, Hay G, Andrews RM, Harris M, Cohen VM, Sagoo MS.

Br J Ophthalmol. 2013 Aug;97(8):1014-9. doi: 10.1136/bjophthalmol-2013-303234. Epub 2013 May 18.

PMID:
23686326
2.

Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.

Papastefanou VP, Pefkianaki M, Al Harby L, Arora AK, Cohen VM, Andrews RM, Sagoo MS.

Eye (Lond). 2016 Jun;30(6):843-9. doi: 10.1038/eye.2016.50. Epub 2016 Apr 1.

3.

Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.

Chiang A, Bianciotto C, Maguire JI, Park CH, Baker PS, Shields JA, Shields CL.

Retina. 2012 Jan;32(1):60-7. doi: 10.1097/IAE.0b013e31822092b7.

PMID:
21886019
4.

Choroidal neovascularization associated with focal choroidal excavation.

Lee JH, Lee WK.

Am J Ophthalmol. 2014 Mar;157(3):710-8.e1. doi: 10.1016/j.ajo.2013.12.011. Epub 2013 Dec 15.

PMID:
24345322
5.

Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.

Costagliola C, Semeraro F, Cipollone U, Rinaldi M, della Corte M, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2009 Aug;247(8):1031-7. doi: 10.1007/s00417-009-1081-y. Epub 2009 Apr 29.

PMID:
19404665
6.

Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.

Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N.

Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.

PMID:
21358461
8.

Focal choroidal excavation complicated by choroidal neovascularization.

Xu H, Zeng F, Shi D, Sun X, Chen X, Bai Y.

Ophthalmology. 2014 Jan;121(1):246-50. doi: 10.1016/j.ophtha.2013.08.014. Epub 2013 Oct 4.

PMID:
24095605
9.

Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.

Khan MA, DeCroos FC, Storey PP, Shields JA, Garg SJ, Shields CL.

Retina. 2014 Sep;34(9):1750-6. doi: 10.1097/IAE.0000000000000187.

PMID:
24936941
10.

Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.

Punjabi OS, Huang J, Rodriguez L, Lyon AT, Jampol LM, Mirza RG.

Br J Ophthalmol. 2013 Aug;97(8):1024-31. doi: 10.1136/bjophthalmol-2013-303155. Epub 2013 Jun 12.

PMID:
23759437
11.

Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.

Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D.

Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.

PMID:
23972309
13.

Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.

Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K.

Br J Ophthalmol. 2012 Mar;96(3):394-9. doi: 10.1136/bjo.2011.204123. Epub 2011 Jun 30.

PMID:
21719568
14.

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.

PMID:
17186262
15.

Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.

Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F.

Retina. 2011 Oct;31(9):1841-7. doi: 10.1097/IAE.0b013e31821800a4.

PMID:
21775926
16.

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.

PMID:
17420694
17.

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.

PMID:
17599414
18.

Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.

Jyothi S, Chowdhury HR, Chong V, Sivaprasad S.

Eye (Lond). 2010 Jun;24(6):1018-23. doi: 10.1038/eye.2009.266. Epub 2009 Nov 6.

PMID:
19893588
19.

Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy.

Cornish KS, Williams GJ, Gavin MP, Imrie FR.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):440-5. doi: 10.5301/EJO.2010.6117.

PMID:
21188681
20.

Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.

Yoon JU, Kim YM, Lee SJ, Byun YJ, Koh HJ.

Retina. 2012 May;32(5):949-55. doi: 10.1097/IAE.0b013e318227a9ef.

PMID:
22534553

Supplemental Content

Support Center